IvanVogelius
@ivanvogelius.bsky.social
Professor and head of medical physics, dept of Oncology, Rigshospitalet, Denmark
Reposted by IvanVogelius
Remember the misleading press about "brutal" #radonc after PROSPECT ?
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
December 15, 2024 at 9:23 PM
Remember the misleading press about "brutal" #radonc after PROSPECT ?
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
This is what modern RT can achieve for elderly breast cancer patients !
👉 "Endocrine Tx was associated with a greater reduction in HRQOL compared with RT at 24 mo"
👉 oncological data awaited
www.thelancet.com/journals/lan...
Reposted by IvanVogelius
In case you may have missed any of the
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
December 5, 2024 at 2:12 PM
In case you may have missed any of the
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
Virtual Grand Rounds in Radiation Oncology lectures
Recordings are 👇
youtube.com/playlist?lis...
Endorsed by:
ESTRO
DEGRO
SASRO
Reposted by IvanVogelius
Four brilliant days in Vienna - with a super engaged multidisciplinary group of participant 🤩 #radonc #medphys
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
December 4, 2024 at 8:32 PM
Four brilliant days in Vienna - with a super engaged multidisciplinary group of participant 🤩 #radonc #medphys
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
I had a few hours tonight to enjoy the Viennese Christmas markets, and now on a (delayed …) night train towards Brussel
@ivanvogelius.bsky.social @cdfuller.bsky.social
Reposted by IvanVogelius
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
There are already many articles for which there is more attention on Bluesky than on other comparable micro-blogging sites, meaning the academic community and the general public have clearly adopted Bluesky as one of its core places to disseminate and discuss new research.
A Place of Joy.
A Place of Joy.
December 3, 2024 at 2:10 PM
Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪
Reposted by IvanVogelius
Introducing the new "NOPE" algorithm
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
December 2, 2024 at 3:01 PM
Introducing the new "NOPE" algorithm
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
This algorithm will tell you "no" all the time. It has been shown to be up to 95% accurate in situations with a prevalence of 5% and *what is even better* even *more accurate* in rarer diseases
Getting ready for day two of ESTRO quantitative methods course. Fantastic group and engaged faculty. Here @cdfuller.bsky.social as a force of nature on “data sharing how and why”
December 2, 2024 at 7:05 AM
Getting ready for day two of ESTRO quantitative methods course. Fantastic group and engaged faculty. Here @cdfuller.bsky.social as a force of nature on “data sharing how and why”
Reposted by IvanVogelius
Virtual Grand Rounds in Radiation Oncology
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
November 28, 2024 at 9:17 AM
Virtual Grand Rounds in Radiation Oncology
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
„Revving Up Gastric Cancer Care: Insights from the TOPGEAR Trial”
Presented by Prof. Karin Haustermans
December 4th 17:00 – 17:30
Link to online meeting 👇
www.usz.ch/veranstaltun...
Endorsed by:
ESTRO
DEGRO
SASRO
99 of 100 patients included this week...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
ClinicalTrials.gov
ClinicalTrials.gov
November 29, 2024 at 7:43 AM
99 of 100 patients included this week...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
Stereotactic Body Radiation Therapy vs. Microwave Ablation for Colorectal Cancer Patients With Metastatic Disease in the Liver
clinicaltrials.gov/study/NCT036...
November 23, 2024 at 10:26 AM
First real post: #job
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
www.regionh.dk
November 19, 2024 at 10:00 PM
First real post: #job
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
We are hiring: We have an open position for a medical physicist. See the job posting here and apply through the portal: www.regionh.dk/job/s%C3%B8g...
Important dates: deadline for applications 12/12 2024, interviews Jan 6-9
Happy to join Bluesky. Let’s see what this brings. I hope to use it for a solid human curated interaction on news in radiotherapy and oncology. Like twitter used to be, just better :-)
November 19, 2024 at 9:59 PM
Happy to join Bluesky. Let’s see what this brings. I hope to use it for a solid human curated interaction on news in radiotherapy and oncology. Like twitter used to be, just better :-)